PFE Stock (Pfizer, Inc.) PFE Stock Analysis | PFE Stock Price Today | November 12, 2025
0:49
YouTubeCandle Point
PFE Stock (Pfizer, Inc.) PFE Stock Analysis | PFE Stock Price Today | November 12, 2025
PFE Stock (Pfizer, Inc.) PFE Stock Analysis | PFE Stock Price Today | November 12, 2025 pfe stock, $pfe stock,pfe stock news, pfe stock price, pfe stock alert,pfe stock chart,pfe stock target, pfe stock update,pfe stock reddit,pfe stock option, pfe stock review, $pfe stock alert,$pfe stock video,pfe stock analysis, pfe stock forecast,pfe stock ...
1 day ago
Pfizer Vaccine
Pfizer vaccine covid | How it works, efficacy and side effects
11:08
Pfizer vaccine covid | How it works, efficacy and side effects
YouTubeShomu's Biology
236.7K viewsMay 18, 2021
Coronavirus Update 116: Pfizer COVID 19 Vaccine Explained (Biontech)
22:32
Coronavirus Update 116: Pfizer COVID 19 Vaccine Explained (Biontech)
YouTubeMedCram - Medical Lectures
697.9K viewsNov 12, 2020
How the Pfizer-BioNTech COVID-19 vaccine was developed
13:31
How the Pfizer-BioNTech COVID-19 vaccine was developed
YouTube60 Minutes
880.7K viewsDec 21, 2020
Top videos
PFE Stock (Pfizer, Inc.) PFE Stock Analysis | PFE Stock Price Today | November 11, 2025
0:44
PFE Stock (Pfizer, Inc.) PFE Stock Analysis | PFE Stock Price Today | November 11, 2025
YouTubeCandle Point
2 days ago
$PFE Pfizer Stock Technical Analysis Report Pfizer PFE Technical Analysis
6:17
$PFE Pfizer Stock Technical Analysis Report Pfizer PFE Technical Analysis
YouTubeHisseseven
22 hours ago
Pfizer Stock forecast nov 2025 | Pfizer Earnings | PFE Stock | Pfizer Earnings | Pfizer Dividend
Pfizer Stock forecast nov 2025 | Pfizer Earnings | PFE Stock | Pfizer Earnings | Pfizer Dividend
YouTubeEveryday TV (ETV)
2 days ago
Pfizer Drugs
Pfizer to buy Metsera in deal worth up to $10 billion
1:17
Pfizer to buy Metsera in deal worth up to $10 billion
YouTubeCNBC Television
445 views2 days ago
Pfizer has clinched a $10 billion deal for obesity drug developer Metsera, capping a fierce biotech bidding war between the New York-based pharma giant and Danish rival Novo Nordisk. Metsera accepted a sweetened offer from Pfizer late on Friday, citing U.S. antitrust risks in Novo’s bid that it had previously called superior. Read more: cnb.cx/3WO8LQK | CNBC
1:17
Pfizer has clinched a $10 billion deal for obesity drug developer Metsera, capping a fierce biotech bidding war between the New York-based pharma giant and Danish rival Novo Nordisk. Metsera accepted a sweetened offer from Pfizer late on Friday, citing U.S. antitrust risks in Novo’s bid that it had previously called superior. Read more: cnb.cx/3WO8LQK | CNBC
FacebookCNBC
1.3K views2 days ago
Pfizer After Covid: Time to Buy or Stay Away?
1:02
Pfizer After Covid: Time to Buy or Stay Away?
YouTubeFinance & Fries
13 hours ago